Cargando…

1646. Optimizing Antibiotic Durations of Therapy in Pediatric Community-acquired Pneumonia

BACKGROUND: Several recent high-quality studies have shown similar efficacy for a shorter, 5-day duration of antibiotics instead of the prior standard, 10 days, in pediatric community-acquired pneumonia (CAP). Despite high-quality literature support, implementing short courses into routine clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cook, Gregory, Sarkar, Shubho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677809/ http://dx.doi.org/10.1093/ofid/ofad500.1480

Ejemplares similares

O01 Auditing the duration of antibiotic therapy for children treated as inpatients for community acquired pneumonia
por: Alexander, Emma, et al.
Publicado: (2023)

146. Predictors of Long Duration Antibiotic Therapy for Urinary Tract Infections and Community-Acquired Pneumonia in Pediatric Ambulatory Care Settings
por: Shah, Rohan M, et al.
Publicado: (2021)

2193. Factors Impacting the Duration of Antimicrobial Therapy for Community-Acquired Pneumonia
por: Sandhu, Avnish, et al.
Publicado: (2019)

2207. Impact of an Intervention Bundle on Azithromycin Use and 5-Day Durations of Therapy for Ambulatory Pediatric Community Acquired Pneumonia
por: Weber, Matthew J, et al.
Publicado: (2023)

Use of MRSA Nasal Swab to Guide Empiric Antibiotic Treatment of Hospital Acquired or Community Acquired Pneumonia in a Pediatric Population
por: Linfesty, Daniel, et al.
Publicado: (2017)

1646. Education Level is Associated with Tetanus Vaccine Coverage: Results from the 2016 BRFSS
por: Rencken, Camerin, et al.
Publicado: (2019)

261. Alternative Antibiotic Prescribing for Community Acquired Pneumonia (CAP) in Pediatric Patients in Relation to Allergy Status
por: Desai, Ankita, et al.
Publicado: (2018)

Optimal duration of antibiotic treatment for community-acquired pneumonia in adults: a systematic review and duration-effect meta-analysis
por: Furukawa, Yuki, et al.
Publicado: (2023)

Antibiotic Prescribing for Pediatric Community-Acquired Pneumonia at Children’s Hospitals and General Hospitals Following National Guideline Release
por: Tribble, Alison, et al.
Publicado: (2017)

519. Longer Length of Antibiotic Therapy for Community-Acquired Pneumonia and Risk of Clostridium difficile Infection
por: Yi, Sarah H, et al.
Publicado: (2018)

68. Impact of a Pharmacy-Driven Antimicrobial Time-out on Duration of Therapy in Community-Acquired Pneumonia
por: Patel, Amolee R, et al.
Publicado: (2020)

879. Intravenous to Oral Antibiotic Switch in Patients Hospitalized with Community-Acquired Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2022)

1027. Vancomycin Use in Community-Acquired Pneumonia: Assessing Inappropriate Therapy
por: Shan, Timothy, et al.
Publicado: (2019)

75. Less is More: A Physician-Driven Quality Improvement Stewardship Initiative to Reduce Excessive Duration of Antibiotic Therapy in Veterans Hospitalized with Community-Acquired Pneumonia
por: Monday, Lea M, et al.
Publicado: (2020)

1646. Combined Resistance Analyses From Phase 2b Studies of Presatovir Treatment in RSV-Infected Adults
por: Porter, Danielle, et al.
Publicado: (2018)

P24 Auditing antibiotic course lengths for the management of community-acquired pneumonia and hospital-acquired pneumonia against current NICE guidance
por: Chua, Elaine, et al.
Publicado: (2023)

Combination antibiotic therapy for community-acquired pneumonia
por: Caballero, Jesus, et al.
Publicado: (2011)

747. Antibiotic Therapy for Community-Acquired Pneumonia: A Systematic Review and Network Meta-Analysis of Randomized Trials
por: Siemieniuk, Reed, et al.
Publicado: (2018)

1449. Antibiotic Choice, Duration, and Outcome in Community-Acquired Urinary Tract Infections (UTI) in Male Patients
por: Chen, Joshua C, et al.
Publicado: (2019)

Duration of Antimicrobial Therapy in Community Acquired Pneumonia: Less Is More
por: Pinzone, Marilia Rita, et al.
Publicado: (2014)

Impact of Personalized Audit and Feedback on Management of Pediatric Outpatient Community-Acquired Pneumonia
por: Handy, Lori, et al.
Publicado: (2017)

99. Comparison of Procalcitonin Testing to a Targeted Audit-and Feedback Strategy on Prescribed Durations of Therapy for Community-Acquired Pneumonia
por: Clark, Lauren, et al.
Publicado: (2020)

Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia
por: Uranga MD, Ane, et al.
Publicado: (2020)

Clinical response to antibiotic therapy for community-acquired pneumonia
por: Juvén, Taina, et al.
Publicado: (2004)

P01 Antibiotic efficacy treatment of community-acquired pneumonia among CMV-infected individuals
por: Chichirelo-Konstantynovych, Kiarina, et al.
Publicado: (2023)

The dilemma of improving rational antibiotic use in pediatric community-acquired pneumonia
por: Nguyen, Phuong T. K., et al.
Publicado: (2023)

Quality of antibiotic prescribing for pediatric community-acquired Pneumonia in outpatient care
por: Saatchi, Ariana, et al.
Publicado: (2023)

Santa Inés Zacatelco (1646-1812) : contribución a la demografía histórica del México colonial
por: Morin, Claude, 1929-
Publicado: (1973)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

Correction to: Impact of reducing the duration of antibiotic treatment on the long-term prognosis of community acquired pneumonia
por: Uranga, Ane, et al.
Publicado: (2021)

1666. A Clinical Care Pathway Improves Antibiotic Prescribing in Hospitalized Children with Community Acquired Pneumonia
por: Schweiger, Jennifer, et al.
Publicado: (2023)

1773. Impact of Antibiotics Used to Treat Community Acquired Pneumonia on the Gut Microbiome and Resistome in Healthy Volunteers
por: Anthony, Winston, et al.
Publicado: (2018)

Comparative Effectiveness of β-lactams Vs Azithromycin for Treatment of Outpatient Pediatric Community-acquired Pneumonia
por: Handy, Lori, et al.
Publicado: (2017)

1460. Community-Acquired Bacteremic Pneumonia in Post-pneumococcal Vaccination Era in a Pediatric Hospital
por: Gentile, Angela, et al.
Publicado: (2018)

Antibiotic preferences and treatment durations in community-acquired infections
por: Ertunc, Baris, et al.
Publicado: (2023)

1192. Validation of an Electronic Dashboard in Identifying Excess Duration of Antibiotics for Pneumonia
por: Ferranti, Mary, et al.
Publicado: (2023)

722. Normal Clinical Signs and Duration of Antibiotics in Hospitalized Patients with Pneumonia
por: Ochoa, Aileen, et al.
Publicado: (2018)

Challenges of Empirical Antibiotic Therapy for Community-Acquired Pneumonia in Children
por: Rodrigues, Charlene M.C.
Publicado: (2017)

1457. Escherichia coli Community Acquired Pneumonia
por: John, Teny Mathew, et al.
Publicado: (2018)

Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia
por: Donà, Daniele, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u84ffhrfe9cl1apsh1oh8sn7bv